Clinical Trials Browser

Phase 1/2 × Advanced Tumors × 90 days × Clear all

NCT07110584 2026-03-05

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

Phase 1/2 Recruiting

Advanced Tumors